INOZYME PHARMA, INC. Restricted Cash
INOZYME PHARMA, INC. had Restricted Cash of $311.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCash · last filed 2025-05-14
- 2025-03-31: Restricted Cash $311.00K.
- 2024-12-31: Restricted Cash $311.00K.
- 2023-12-31: Restricted Cash $0.00.
- 2022-12-31: Restricted Cash $400.00K.
| Period end | Restricted Cash |
|---|---|
| 2025-03-31 | $311.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $311.00K 10-Q · filed 2025-05-14 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-10 |
| 2022-12-31 | $400.00K 10-K · filed 2023-03-22 |
| 2022-09-30 | $400.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $400.00K 10-Q · filed 2022-08-15 |
| 2021-12-31 | $400.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $400.00K 10-Q · filed 2022-11-10 |
| 2021-06-30 | $400.00K 10-Q · filed 2022-08-15 |